- Home
- Services
- north america
- cancer diagnostic
Show results for
Refine by
Cancer Diagnostic Services In North America
16 services found
by:Avero Diagnostics based inIrving, TEXAS (USA)
Our sub-specialized pathology services provide expertise in the areas of breast, gynecologic, gastrointestinal, molecular, and urology ...
Manufactured by:MiraDx based inLos Angeles, CALIFORNIA (USA)
Independent of their BRCA1/BRCA2 mutational status, ...
Manufactured by:RareStone Group based inShanghai, CHINA
In recent years, the incidence of childhood cancer has been on the rise, and malignant tumor has become one of the main causes of death among adolescents. More than 250,000 children worldwide are diagnosed with cancer each year, and about 90,000 children die of cancer—making it the leading cause of death among children. In addition to leukemia, malignant lymphoma and other blood tumors, ...
by:Envision Radiology based inColorado Springs, COLORADO (USA)
A mammogram procedure is simply an X-ray image of your breast. Mammography uses a low dose X-ray to look for early signs of breast cancer, such as lumps that are too small to be felt either by yourself or your healthcare provider. A mammogram can also show changes in your breast tissue which could indicate early-stage breast cancer. Our radiologists use digital mammogram imaging to both locate ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
The goal of the French Kidney Cancer Research Network (Réseau Français de Recherche sur le Cancer du Rein) is to connect a National, multidisciplinary network of medical and scientific professionals who focus on therapeutic management and applied research into kidney cancer. Today, the UroCCR network includes 53 multidisciplinary clinical teams across France and Belgium. It is ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Development of a Blood Test with Prospective Study Cohort of 100,000 Participants. The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
by:Jasper Health, Inc. based inBoise, IDAHO (USA)
Behavior Change At Scale. Jasper Health Care Coaches can: Augment existing coaching & care management teams, Deliver psychosocial support coaching, Train existing coaches and care management teams on psychosocial support, Connect the dots in a disconnected health care system and connect to health plan resources, Be your employee coaching service for cancer and other serious ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. SUMMIT aims to further evaluate GRAIL’s blood ...
Manufactured by:UroTech based inFranklin, TENNESSEE (USA)
UroTech is devoted to keeping pace with the growing need for better and more widespread brachytherapy services. Like UroTech's thermotherapy and lithotripsy services, UroTech delivers top of the line equipment and expertise to facilities seeking to improve their services for prostate cancer. We work hand in hand with radiation oncologists, physicists, and urologists to develop Centers of ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
by:xCures based inOakland, CALIFORNIA (USA)
xCures’ patient-centric focus ensures that advanced cancer patients continuously engage with the xCures platform. Patients and their treating physicians receive decision support and access to leading therapeutics and diagnostics in return for ongoing access to their electronic medical records throughout their cancer journey. This direct ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
Histology, tissue staining using the latest in automated staining platforms, and digital pathology services form the foundation of a strong anatomic pathology program. Anatomic Pathology at NeoGenomics offers in-house comprehensive diagnostic services, backed by highly trained professionals, to provide oncologists and pathologists the information they need to determine the best treatment strategy ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken in the community setting as well as a doctor’s surgery. Shown ...
Manufactured by:Data Driven Diagnostic Sciences (D3Sciences) based inTucson, ARIZONA (USA)
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and pathologists. Upon examining a patient, and assessing the indicators for the presence of the disease, the oncologist consults with the radiologist and the decision is made for the radiologist ...
by:SoBran Inc. based inFairfax, VIRGINIA (USA)
Our scientific and technical experts assemble customized research programs with attention to your specific project requirements, timelines and budget. To support small animal preclinical toxicology and drug discovery, we offer an expanding range of services that meet GLP and non-GLP compliant in vivo research requirements. Program management is certified to the ISO 9001:2008 standard. ...